TargetMol

Tiemonium iodide

Product Code:
 
TAR-T24882
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24882-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24882-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24882-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Tiemonium iodide is a muscarinic receptor antagonist. It is also an anticholinergic and a parasympatholytic.
CAS:
6252-92-2
Formula:
C18H24INO2S
Molecular Weight:
445.36
Purity:
0.98
SMILES:
[I-].C[N+]1(CCC(O)(c2cccs2)c2ccccc2)CCOCC1

References

1. Shang Y, Zhang X, Chen L, Leng W, Lei X, Yang Q, Liang Z, Wang J. Assessment of Left Ventricular Structural Remodelling in Patients with Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance. J Diabetes Res. 2016;2016:4786925. doi: 10.1155/2016/4786925. Epub 2016 Jun 22. PubMed PMID: 27419144; PubMed Central PMCID: PMC4933864. 2. Guo Y, Liu C, Hu L, Wang X, Alam M, Wang H. An economic method to build a puffing instrument for drug application in vitro. J Neurosci Methods. 2015 Dec 30;256:122-6. doi: 10.1016/j.jneumeth.2015.08.032. Epub 2015 Sep 4. PubMed PMID: 26343324. 3. Biradar DB, Zhou S, Gau HM. Direct asymmetric catalytic thienylaluminum addition to ketones: a concise approach to the synthesis of (S)-tiemonium iodide. Org Lett. 2009 Aug 6;11(15):3386-9. doi: 10.1021/ol901193q. PubMed PMID: 19588914. 4. Klouz A, Za?em A, Trabelsi S, Loueslati MH, Lakhal M, Belkahia C. Orofacial dyskinesia associated with tiemonium. Fundam Clin Pharmacol. 2007 Dec;21(6):657-8. PubMed PMID: 18034667.